Fundz

Repare Therapeutics Appoints Steve Forte as President and CEO

RECENTLY ACQUIREDApr 01, 2025

Position

Senior Vice President of Finance

Company

Repare Therapeutics

Sandra Alves
salves@reparerx.com
BiotechnologyHealth CareTherapeutics

Description

Steve Forte has been appointed as President and Chief Executive Officer of Repare Therapeutics, effective April 11, 2025. He will continue to serve as the Chief Financial Officer while succeeding Lloyd M Segal. Additionally, Sandra Alves has been promoted to Chief Accounting Officer.

Quick answer

Repare Therapeutics Appoints Steve Forte as President and CEO (April 1, 2025).

What did Repare Therapeutics announce on April 1, 2025?
Steve Forte has been appointed as President and Chief Executive Officer of Repare Therapeutics, effective April 11, 2025. He will continue to serve as the Chief Financial Officer while succeeding Lloyd M Segal.
What does Repare Therapeutics do?
Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.
Which similar companies made leadership changes around the same time?
VectorY (April 1, 2025), Cantargia AB (April 1, 2025), Geneoscopy (April 2, 2025) and Verrica (March 26, 2025) also announced leadership changes within 45 days of Repare Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Repare Therapeutics, and when

A new leader at Repare Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Repare Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Repare Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Repare Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Repare Therapeutics

About

Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s clinical-stage pipeline includes RP-3467, a Phase 1 Polθ ATPase inhibitor; and RP-1664, a Phase 1 PLK4 inhibitor.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Repare Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Steve
Likely contact at this company
••••••••@••••••••

See Steve's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Repare Therapeutics's next move

Learn about Strategic plan

Repare Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.